← Back to headlines
Werewolf Therapeutics Reports Q4 GAAP EPS Beat
Werewolf Therapeutics announced a GAAP EPS of -$0.20, beating analyst estimates by $0.14.
27 Mar, 11:03 — 27 Mar, 11:03
Sources
Showing 1 of 1 sources
Related Stories
Asian Markets Slide as US-Iran Clashes Drive Up Oil Prices
43m ago
US Treasury Secretary Urges Bank of Japan to Maintain Sound Monetary Policy Amid Yen Volatility
1h ago
BOJ to debate rate rise, inflation much closer to 2% target: governor
1h ago
Apple Announces Executive Compensation Packages for Ternus and Cook
2h ago